
136: What Happens After You Stop a GLP1?
We break down what the research says happens after stopping GLP-1 medications like semaglutide and tirzepatide, including the scale, hunger signals, and key lab changes. We explain the biology behind rebound and why weight regain is predictable physiology rather than a willpower problem.
• GLP-1s as long-term management for obesity and type 2 diabetes, not a cure
• what GLP-1 does in the brain, stomach, and pancreas and what reverses after stopping
• STEP 1 extension numbers showing about two-thirds regain over a year after stopping Wegovy
• meta-analysis findings on average regain after semaglutide or tirzepatide
• why bigger losses often come with bigger rebounds and why regain is typically gradual
• body composition concerns, regain tending to be more fat than muscle
• what happens to A1C, fasting glucose, blood pressure, and cholesterol after discontinuation
• set point, metabolic adaptation, and counter-regulatory appetite signals
• legitimate reasons people stop and why stopping should be a planned transition
You can find us on Instagram, threads. You can send us an in um a voicemail.
Production and Content: Edward Delesky, MD, DABOM & Nicole Aruffo, RN
Artwork Rebrand and Avatars:
Vantage Design Works (Vanessa Jones)
Website: https://www.vantagedesignworks.com/
Instagram: https://www.instagram.com/vantagedesignworks?igsh=aHRuOW93dmxuOG9m&utm_source=qr
Original Artwork Concept: Olivia Pawlowski
Altri episodi di "Your Checkup: Patient Education Health Podcast"



Non perdere nemmeno un episodio di “Your Checkup: Patient Education Health Podcast”. Iscriviti all'app gratuita GetPodcast.








